We are live on
!
Find out more
Lazard Asset Management Portfolio holdings
AUM
$60.8B
1-Year Est. Return
22.47%
This Fund
S&P 500
This Quarter
Est. Return
+8.56%
1 Year Est. Return
+22.47%
3 Year Est. Return
+62.53%
5 Year Est. Return
+77.87%
10 Year Est. Return
+305.76%
AUM
$82.3B
AUM Growth
+$3.23B
(+4.1%)
Cap. Flow
-$7.73B
Cap. Flow
% of AUM
-9.4%
Top 10 Holdings %
Top 10 Hldgs %
24.03%
Holding
2,474
New
201
Increased
562
Reduced
953
Closed
424
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$983M |
| 2 |
Exelon
EXC
|
+$595M |
| 3 |
Broadcom
AVGO
|
+$486M |
| 4 |
CRH
CRH
|
+$387M |
| 5 |
Marvell Technology
MRVL
|
+$274M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$795M |
| 2 |
Norfolk Southern
NSC
|
+$559M |
| 3 |
PPL
PPL Corp
PPL
|
+$355M |
| 4 |
Union Pacific
UNP
|
+$328M |
| 5 |
Cisco
CSCO
|
+$283M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.45% |
| 2 | Financials | 14.25% |
| 3 | Healthcare | 13.09% |
| 4 | Industrials | 10.08% |
| 5 | Consumer Discretionary | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1701
Genpact
G
$5.76B
| $13K | ﹤0.01% |
398
-1,625
| -80% | -$56.5K |
|
1702
VirTra
VTSI
$34.5M
| $13K | ﹤0.01% |
1,276
+908
| +247% | +$9.71K |
|
|
TBRG
1703
DELISTED
TruBridge
TBRG
| $13K | ﹤0.01% |
1,440
-28
| -2% | -$271 |
|
1704
Adicet Bio
ACET
$74.7M
| $12K | ﹤0.01% |
338
+169
| +100% | +$6.99K |
|
1705
Steven Madden
SHOO
$3.55B
| $12K | ﹤0.01% |
286
-416,296
| -100% | -$17.5M |
|
1706
Travelzoo
TZOO
$75.4M
| $11K | ﹤0.01% |
+1,116
| New | +$10.3K |
|
1707
CI&T Inc
CINT
$458M
| $10K | ﹤0.01% |
+2,573
| New | +$11.6K |
|
1708
ResMed
RMD
$30.7B
| $10K | ﹤0.01% |
52
| – | – |
|
|
ADVM
1709
DELISTED
Adverum Biotechnologies
ADVM
| $9K | ﹤0.01% |
700
-293
| -30% | -$4.46K |
|
1710
Conagra Brands
CAG
$7.23B
| $9K | ﹤0.01% |
325
| – | – |
|
|
JAMF
1711
DELISTED
Jamf
JAMF
| $9K | ﹤0.01% |
+526
| New | +$9.87K |
|
1712
El Pollo Loco
LOCO
$462M
| $9K | ﹤0.01% |
950
-4,144
| -81% | -$37.3K |
|
1713
Pitney Bowes
PBI
$2.39B
| $9K | ﹤0.01% |
+2,102
| New | +$8.67K |
|
1714
ProQR Therapeutics
PRQR
$265M
| $9K | ﹤0.01% |
4,147
-1,713
| -29% | -$3.66K |
|
1715
uniQure
QURE
$3.22B
| $9K | ﹤0.01% |
1,958
-1,082
| -36% | -$6.21K |
|
1716
Scilex Holding
SCLX
$48.9M
| $9K | ﹤0.01% |
162
| – | – |
|
1717
Chegg
CHGG
$102M
| $8K | ﹤0.01% |
1,145
-383,610
| -100% | -$3.51M |
|
1718
Direct Digital Holdings
DRCT
$1.91M
| $8K | ﹤0.01% |
2
| – | – |
|
1719
Lineage Cell Therapeutics
LCTX
$278M
| $8K | ﹤0.01% |
6,059
-3,356
| -36% | -$3.81K |
|
1720
Abeona Therapeutics
ABEO
$413M
| $7K | ﹤0.01% |
+1,124
| New | +$7.12K |
|
|
CVAC
1721
DELISTED
CureVac
CVAC
| $7K | ﹤0.01% |
2,568
-1,422
| -36% | -$4.99K |
|
|
DQ
1722
Daqo New Energy
DQ
$996M
| $7K | ﹤0.01% |
+279
| New | +$6.23K |
|
1723
Innodata
INOD
$2.04B
| $7K | ﹤0.01% |
1,064
-4,162
| -80% | -$34.6K |
|
1724
Prime Medicine
PRME
$559M
| $7K | ﹤0.01% |
1,114
-618
| -36% | -$4.69K |
|
1725
Acme United Corp
ACU
$215M
| $6K | ﹤0.01% |
147
+90
| +158% | +$4.08K |
|
Similar funds
QCM
Lazard Asset Management's Q1 2024 Portfolio in Review
As of Q1 2024, Lazard Asset Management held 2,474 positions worth $82.3B, up 4.1% from $79B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Lazard Asset Management withdrew a net $7.73B in Q1 2024, closing 424 positions and reducing 953 holdings. Its most notable exit was PPL Corp, an estimated $355M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Lazard Asset Management opened a new position in GMO US Quality ETF worth $10.8M.
- Lazard Asset Management's largest Q1 2024 buy was GMO US Quality ETF: 362,290 shares worth $10.8M.
- Lazard Asset Management added most to Apple in Q1 2024, an estimated $983M increase.
- Lazard Asset Management's biggest Q1 2024 reduction was Alphabet (Google) Class A, cutting an estimated $795M.
- Lazard Asset Management fully exited PPL Corp in Q1 2024, selling an estimated $355M.
- Lazard Asset Management's ten largest holdings make up 24% of its $82.3B portfolio in Q1 2024.
- Lazard Asset Management opened 201 new positions and closed 424 in Q1 2024.
- Lazard Asset Management's portfolio value rose 4.1% quarter-over-quarter to $82.3B.
Based on Lazard Asset Management's 13F filing for Q1 2024, filed 14 May 2024.